Patients should be monitored closely to ensure that the lowest approved dose of Nespo is used to provide adequate control of the symptoms of anaemia.
Patienterne skal overvåges nøje for at sikre, at der anvendes den lavest godkendte Nespo- dosis til at kontrollere symptomerne på anæmi i tilstrækkelig grad.